• Grail released a medical research poster evaluating how multi-cancer early detection blood testing could reduce emergency department involvement at cancer diagnosis in a modeled Medicare-age screening cohort.
• The analysis projected a 51% overall reduction in cancers diagnosed with ED involvement versus usual care, with larger reductions in later-stage disease, including 61% in stage III and 70% in stage IV.
• The model estimated that incorporating ED avoidance increased gains from screening to 0.18 life years and 0.13 QALYs per person screened, up from 0.12 life years and 0.09 QALYs when only stage shift effects were counted.
• ED avoidance accounted for 31% of projected QALY gains, with the remainder attributed to stage shift, supporting a broader value case for MCED screening beyond earlier-stage detection alone.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.